Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

KalVista Pharmaceuticals (KALV) Other Non Operating Income: 2013-2025

Historic Other Non Operating Income for KalVista Pharmaceuticals (KALV) over the last 13 years, with Apr 2025 value amounting to $4.8 million.

  • KalVista Pharmaceuticals' Other Non Operating Income fell 12.87% to $2.1 million in Q2 2025 from the same period last year, while for Apr 2025 it was $8.4 million, marking a year-over-year decrease of 17.07%. This contributed to the annual value of $4.8 million for FY2025, which is 50.73% down from last year.
  • According to the latest figures from FY2025, KalVista Pharmaceuticals' Other Non Operating Income is $4.8 million, which was down 50.73% from $9.8 million recorded in FY2024.
  • Over the past 5 years, KalVista Pharmaceuticals' Other Non Operating Income peaked at $15.6 million during FY2023, and registered a low of $4.8 million during FY2025.
  • In the last 3 years, KalVista Pharmaceuticals' Other Non Operating Income had a median value of $9.8 million in 2024 and averaged $10.1 million.
  • In the last 5 years, KalVista Pharmaceuticals' Other Non Operating Income soared by 48.26% in 2022 and then plummeted by 50.73% in 2025.
  • KalVista Pharmaceuticals' Other Non Operating Income (Yearly) stood at $9.9 million in 2021, then surged by 48.26% to $14.7 million in 2022, then rose by 6.26% to $15.6 million in 2023, then crashed by 37.56% to $9.8 million in 2024, then crashed by 50.73% to $4.8 million in 2025.